CJC/Ipamorelin Vial
$228.00
CJC (no DAC) / Ipamorelin 10 mL Vial
The Science, Simplified: This dual-peptide research blend combines CJC (no DAC) / Modified GRF (1-29), a tetrasubstituted GHRH analog, with Ipamorelin, a selective growth hormone secretagogue (ghrelin mimetic).
Product Specifications – CJC (no DAC) / Ipamorelin 10 mL Vial (10 mg / 10 mg)
- Total CJC (no DAC): 10 mg; Total Ipamorelin: 10 mg
- Volume: 10 mL vial
- Concentration: 1 mg/mL CJC (no DAC) + 1 mg/mL Ipamorelin
- Purity: Research-grade, third-party tested (COA available)
- Format: Ready-to-use liquid vial
Key Research Focus: Enables side-by-side GHRH-receptor and ghrelin-receptor pathway work from one sealed unit in controlled GH-axis laboratory models.
Physical Form & Solubility:
- Appearance: Clear to slightly opalescent liquid
- Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.
Stability & Handling Notes:
- Refrigerated at 36-46°F. Practical shelf life is 16-20 weeks when protected from light and handled with aseptic technique.
- Do not freeze. Avoid prolonged room-temperature exposure.
- Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
- Protect from light and moisture at all times.
- For lyophilized orders please contact us (minimum order required)
https://www.palmbeach-vitality.com
CJC (no DAC) 10 mg / Ipamorelin 10 mg blend research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.
How Labs Use This Format: Labs use this single sealed multi-component liquid vial when both a GHRH analog and a selective GHRP should be available for side-by-side pathway assays without opening two containers. Pipette aliquots using aseptic technique. A CJC/Ipamorelin pen format may be available in the peptide pens category.
Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records. Cold-pack shipping on qualifying orders.
CJC-1295 / Ipamorelin Research Studies
Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.
Read the CJC-1295 / Ipamorelin research overview
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting GH releasing hormone analogPubMed 16352683
- Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, enhances GH and IGF-I secretionPubMed 16822960
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changesPubMed 19386527
- Ipamorelin, the first selective growth hormone secretagoguePubMed 9849822
- Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileusPubMed 19289567
